Source: Eur Respir J, 55 (2) 1900506; 10.1183/13993003.00506-2019



Rating:

Share or cite this content

Citations should be made in the following way:
Hans-Ulrich Kauczor, Anne-Marie Baird, Torsten Gerriet Blum, Lorenzo Bonomo, Clementine Bostantzoglou, Otto Burghuber, Blanka Cepická, Alina Comanescu, Sébastien Couraud, Anand Devaraj, Vagn Jespersen, Sergey Morozov, Inbar Nardi Agmon, Nir Peled, Pippa Powell, Helmut Prosch, Sofia Ravara, Janette Rawlinson, Marie-Pierre Revel, Mario Silva, Annemiek Snoeckx, Bram van Ginneken, Jan P. van Meerbeeck, Constantine Vardavas, Oyunbileg von Stackelberg, Mina Gaga. ESR/ERS statement paper on lung cancer screening. Eur Respir J, 55 (2) 1900506; 10.1183/13993003.00506-2019

Member's Comments

No comment yet.

Related content which might interest you: ESR/ERS white paper on lung cancer screening Source: Eur Respir J 2015; 46: 28-39 Year: 2015 Introduction on the ESR/ERS statement on low-dose lung cancer screening Source: International Congress 2019 – NELSON: the Trafalgar of lung cancer screening? Year: 2019 ERS statement on harmonised standards for lung cancer registration and lung cancer services in Europe Source: Eur Respir J, 52 (6) 1800610; 10.1183/13993003.00610-2018 Year: 2018 ERS statement on harmonised standards for lung cancer registration and lung cancer services in Europe Source: International Congress 2018 – State of the art session: Thoracic oncology Year: 2018 ERS statement on harmonised standards for lung cancer registration and lung cancer services in Europe Source: Guideline 2018 Year: 2018 The ALA/ATS implementation guide on lung cancer screening Source: International Congress 2018 – Imminent global problems in lung cancer require joint action: time for an international alliance! Year: 2018 Lung cancer screening: the critical review Source: International Congress 2015 – Lung cancer screening: how to implement a comprehensive preventive approach Year: 2015 A study of the public‘s awareness of the causation of lung cancer Source: Eur Respir J 2005; 26: Suppl. 49, 184s Year: 2005 An abnormal CT, now what: issues in the diagnosis and management of a patient with a potential lung cancer Source: Annual Congress 2006 - MP11 - An abnormal CT, now what: issues in the diagnosis and management of a patient with a potential lung cancer Year: 2006 A study of design an original questionnaire for evaluating risks of lung cancer Source: Annual Congress 2011 - Epidemiology of lung cancer and screening Year: 2011 Emphysema, COPD and lung cancer screening. Update of an ongoing study Source: Annual Congress 2012 - Screening, diagnosis, staging and treatment strategies for lung cancer Year: 2012 Management of lung cancer screening and incidental findings as well as their integration in existing lung cancer care Source: International Congress 2019 – PG1 Lung cancer: the key multidisciplinary approach Year: 2019 Molecular test supporting early lung cancer detection project based on pilot Pomeranian lung cancer screening program Source: Annual Congress 2011 - Epidemiology of lung cancer and screening Year: 2011 Evolution in the pathological study of lung cancer Source: Virtual Congress 2020 – Management issues in thoracic oncology Year: 2020 Re-audit of adherence to NICE guidelines on investigation of lung cancer Source: Annual Congress 2007 - Diagnosis of thoracic malignancies Year: 2007 Evolution in the diagnostic approach to lung cancer Source: Virtual Congress 2021 – COVID-19 and management of lung cancer Year: 2021 Patient perspectives and experience on the diagnostic pathway of lung cancer – a qualitative study Source: International Congress 2018 – Contemporary respiratory care: symptoms, the role of the nurse and the organisation of care Year: 2018 Lung cancer screening white paper: a slippery step forward? Source: Eur Respir J 2015; 46: 1521-1522 Year: 2015 Lung cancer screening white paper: a slippery step forward? Source: Eur Respir J 2015; 46: 1519-1520 Year: 2015